Levels of serum cytokines, such as IL-6, IL-1β, IL-1α, IL-8, IL-12p40, IL-13, GM-CSF, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MP)-1α, MP-1β, IFNα, tumor necrosis factor (TNF)-α, epidermal growth factor, VEGF and TNF receptor II are reported to be significantly higher in patients with breast cancer and with resected high-risk melanoma than in healthy controls (24,25). The gene discussed is CCL2; the disease is breast carcinoma.